Does EU legislation allow the use of the Benchmark Dose (BMD) approach for risk assessment?
Brandon EF, Bulder AS, van Engelen JG, Mahieu CM, Mennes WC, Pronk ME, Rietveld AG, van de Ven BM, Ten Voorde SE, Wolterink G, Slob W, Zeilmaker MJ, Bessems JG.
Brandon EF, et al. Among authors: slob w.
Regul Toxicol Pharmacol. 2013 Nov;67(2):182-8. doi: 10.1016/j.yrtph.2013.07.005. Epub 2013 Jul 16.
Regul Toxicol Pharmacol. 2013.
PMID: 23871753